NEWTOWN, PA--(Marketwire - Sep 12, 2012) - Sylogent today announced the launch of ProSTRAT, a new internet-based application that streamlines the way that pharmaceutical companies move documents through their approval process.
"Our experience revealed that major pharmaceutical companies typically route proprietary information through a mixture of home-grown systems, off-line conversations and random emails," stated Jack Yeager, CEO of Sylogent. "This creates the bad combination of a high-risk task and inefficient process, which is easily solved with our technology."
ProSTRAT organizes and standardizes the process by enabling any individual to upload a document into the system, which is then automatically assigned to the appropriate stakeholders. "This web-based tool is ideal for any company that must protect their proprietary information while adhering to numerous compliance regulations without overburdening their employees," stated Yeager.
ProSTRAT integrates with Sylogent's industry-leading Journal Selector and Conference Authority databases, along with a newly revamped Cite Central Repository, providing companies with a complete system from target selection through approval tracking to document storage.
Sylogent has extensive experience in data aggregation, workflow automation, and document management gained through its other applications, which are currently deployed at leading pharmaceutical companies and include PubSTRAT, VCTR, SylogiQ, and SytriQs.
"Our mission is to drive compliance and minimize employee workload while saving our clients millions of dollars in unnecessary costs," said Yeager. The company already has deployed the ProSTRAT application at one major pharmaceutical company and expects to complete deployment at another within thirty days.
Sylogent provides software solutions to the pharmaceutical, biotech and medical device industries. The company focuses on innovative internet-based applications that automate and simplify core business processes.